Surgical Care Science, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Research Unit of Surgery, Anaesthesia and Intensive Care, Oulu University Hospital, University of Oulu, Oulu, Finland.
Br J Surg. 2021 Jun 22;108(6):702-708. doi: 10.1002/bjs.11998. Epub 2020 Oct 9.
Minimally invasive oesophagectomy has been shown to reduce the risk of pulmonary complications compared with open oesophagectomy, but the effects on health-related quality of life (HRQoL) and oesophageal cancer survivorship remain unclear. The aim of this study was to assess the longitudinal effects of minimally invasive compared with open oesophagectomy for cancer on HRQoL.
All patients who had surgery for oesophageal cancer in Sweden from January 2013 to April 2018 were identified. The exposure was total or hybrid minimally invasive oesophagectomy, compared with open surgery. The study outcome was HRQoL, evaluated by means of the European Organisation for Research and Treatment of Cancer questionnaires QLQ-C30 and QLQ-OG25 at 1 and 2 years after surgery. Mean differences and 95 per cent confidence intervals were adjusted for confounders.
Of the 246 patients recruited, 153 underwent minimally invasive oesophagectomy, of which 75 were hybrid minimally invasive and 78 were total minimally invasive procedures. After adjustment for age, sex, Charlson Co-morbidity Index score, pathological tumour stage and neoadjuvant therapy, there were no clinically and statistically significant differences in overall or disease-specific HRQoL after oesophagectomy between hybrid minimally invasive and total minimally invasive surgical technique versus open surgery.
In this population-based nationwide Swedish study, longitudinal HRQoL after minimally invasive oesophagectomy was similar to that of the open surgical approach.
与开放性食管切除术相比,微创食管切除术已被证明可降低肺部并发症的风险,但对健康相关生活质量(HRQoL)和食管癌生存的影响仍不清楚。本研究旨在评估与开放性食管切除术相比,微创治疗癌症对 HRQoL 的纵向影响。
在瑞典,从 2013 年 1 月至 2018 年 4 月期间,所有接受食管癌手术的患者均被确定。暴露因素是全或杂交微创食管切除术与开放性手术相比。研究结果是通过欧洲癌症研究与治疗组织问卷 QLQ-C30 和 QLQ-OG25 在手术后 1 年和 2 年评估的 HRQoL。均值差异和 95%置信区间经混杂因素调整。
在招募的 246 名患者中,有 153 名患者接受了微创食管切除术,其中 75 名患者接受了杂交微创食管切除术,78 名患者接受了全微创食管切除术。在调整年龄、性别、Charlson 合并症指数评分、病理肿瘤分期和新辅助治疗后,与开放性手术相比,杂交微创和全微创手术技术的总体或疾病特异性 HRQoL 在食管切除术后无临床和统计学显著差异。
在这项基于人群的全国性瑞典研究中,微创食管切除术后的 HRQoL 与开放性手术相似。